Selective neuronal degeneration induced by soluble oligomeric amyloid beta‐protein
Top Cited Papers
- 1 November 2002
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 17 (1) , 118-120
- https://doi.org/10.1096/fj.01-0987fje
Abstract
The prevailing amyloid hypothesis for Alzheimer's disease (AD) holds that amyloid beta-protein (Abeta) causes neuronal degeneration by forming neurotoxic fibrillar structures. Yet, many aspects of AD pathology and symptoms are not well explained by this hypothesis. Here, we present evidence that neurotoxicity of soluble oligomeric Abeta closely corresponds to the selective neurodegeneration so distinctly manifest in AD. Selectivity was first observed in vitro, where only the human central nervous system neuronal cells were susceptible to soluble oligomeric Abeta. Furthermore, in mouse cerebral slice treated with soluble oligomeric Abeta, selective regiospecific toxicity was evident in the hippocampal CA1, a division important for memory, but not in the CA3 subfield. The fibrillar Abeta, however, killed neurons in all regions of the cerebral slice cultures and also in cerebellar slices. Remarkably, even at the highest soluble oligomeric Abeta concentrations, cerebellar neurons were completely spared, consistent with one of the hallmark features of AD pathology. Our observation of the selective neurodegeneration of soluble oligomeric Abeta to neurons involved in cognitive function may provide a new opportunity for the development of an effective AD therapy as well as elucidating the pathological mechanism of AD.Keywords
Funding Information
- Korea Science and Engineering Foundation (R02-200000185)
This publication has 43 references indexed in Scilit:
- Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis11Edited by F. CohenJournal of Molecular Biology, 2001
- The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formationNature Neuroscience, 2001
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Genetic Classification of Primary Neurodegenerative DiseaseScience, 1998
- Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer diseaseBrain Research, 1998
- Amyloid ? protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor proteinJournal of Comparative Neurology, 1998
- Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohortsBrain Research Reviews, 1997
- Water-soluble Aβ(N-40, N-42) Oligomers in Normal and Alzheimer Disease BrainsJournal of Biological Chemistry, 1996
- β-Amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neuronsBiochemical and Biophysical Research Communications, 1991
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984